nivolumab,ipilimumab
bms
['diciple']
 a retrospective study of an already recommended standard. what about diciple an ifct-sponsored phase2r assess g earky stop at 6 mo in pts with dcr? asco 2023 results 
MD, PhD. Head of Thoracic Oncology Dpt. Bichat-Claude Bernard University Hospital, AP-HP, Université Paris Cité; Inserm Lab U830, Institut Curie Research Center